BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/27/2021 5:24:00 AM | Browse: 809 | Download: 2088
Publication Name World Journal of Hepatology
Manuscript ID 68321
Country Italy
ISSN 1948-5182 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Pediatrics
Manuscript Type Retrospective Study
Article Title Use of oral vancomycin in children with autoimmune liver disease: A single centre experience
Manuscript Source Invited Manuscript
All Author List Angelo Di Giorgio, Anna Tulone, Emanuele Nicastro, Lorenzo Norsa, Aurelio Sonzogni and Lorenzo D'Antiga
ORCID
Author(s) ORCID Number
Angelo Di Giorgio http://orcid.org/0000-0003-0363-5565
Anna Tulone http://orcid.org/0000-0002-7112-2182
Emanuele Nicastro http://orcid.org/0000-0002-4518-9375
Lorenzo Norsa http://orcid.org/0000-0003-3322-2921
Aurelio Sonzogni http://orcid.org/0000-0001-5001-9533
Lorenzo D'Antiga http://orcid.org/0000-0001-7150-3148
Funding Agency and Grant Number
Corresponding Author Angelo Di Giorgio, MD, PhD, N/A, N/A, Pediatric Hepatology, Gastroenterology and Transplantation, Hospital Papa Giovanni XXIII , Piazza Oms 1, Bergamo 24127, Italy. adigiorgio@asst-pg23.it
Key Words Autoimmune hepatitis; Autoimmune sclerosing cholangitis; Autoimmune liver disease; Vancomycin; Children; Liver transplantation
Core Tip Experience with oral vancomycin in children with autoimmune liver disease (AILD) is limited. We enrolled 75 children [median age 10.5 years (5.6-13.4)], 54 with autoimmune hepatitis and 21 with autoimmune sclerosing cholangitis; 63/75 achieved remission by standard immunosuppressive (IS) therapy, whereas 12/75 (16%) required oral vancomycin treatment (OVT). In 6/12 patients (50%) the response was complete, whereas it was partial in 2/12 (17%), and absent in 4/12 (33%). Overall OVT increased the remission rate of the whole group of AILD patients from 81% to 92%. OVT may represent a valuable treatment option in children with AILD who do not respond to standard IS.
Publish Date 2021-12-27 05:24
Citation Di Giorgio A, Tulone A, Nicastro E, Norsa L, Sonzogni A, D'Antiga L. Use of oral vancomycin in children with autoimmune liver disease: A single centre experience. World J Hepatol 2021; 13(12): 2113-2127
URL https://www.wjgnet.com/1948-5182/full/v13/i12/2113.htm
DOI https://dx.doi.org/10.4254/wjh.v13.i12.2113
Full Article (PDF) WJH-13-2113.pdf
Full Article (Word) WJH-13-2113.docx